# 2022-04-27

## English
An Omicron-specific COVID-19 vaccine candidate developed by domestic producer
Sinopharm has been approved for clinical trials by China's top drug regulator,
the company said on Tuesday.
Clinical trials will be rolled out among people above 18 who have
already been vaccinated with two or three doses of COVID-19 vaccines.


## words
* Omicron: 奥密克戎
* vaccine: 疫苗
* candidate: 候选
* Sinopharm: 国药控股
* clinical trial: 临床试验
* China's top drug regulator: 中国最高药品监管机构
* roll out: 展开
* dose: 剂量